Stay updated on Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial

Sign up to get notified when there's something new on the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Footer Revision updated from v3.4.2 to v3.4.3; no changes to study content or data.
    Difference
    0.1%
    Check dated 2026-03-11T20:07:24.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Addition of Revision: v3.4.2 and removal of the government funding status notice appear to be site housekeeping; no changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T05:43:33.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Added a site-wide government funding status notice and updated the site revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.5%
    Check dated 2026-02-04T05:39:20.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Show glossary added; the QC criteria label text and capitalization changed (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a site revision indicator shows 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:14:23.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.4, replacing the previous v3.3.3; this change does not affect the study details or any user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:01:08.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    A dedicated Locations section now lists Ontario as a study site. The page footer shows Revision: v3.3.3, and the old Ontario Locations entry and the HHS Vulnerability Disclosure note were removed.
    Difference
    0.2%
    Check dated 2025-12-23T09:25:55.000Z thumbnail image

Stay in the know with updates to Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page.